LG Chem
Clinical trials sponsored by LG Chem, explained in plain language.
A major South Korean chemical and pharmaceutical company, subsidiary of LG Corp.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
One shot, six protections: could a single vaccine replace multiple infant shots?
Vaccine OngoingThis trial tests a new vaccine called LBVD, which combines protection against six diseases: diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib. The study enrolls healthy infants around 6 to 8 weeks old who receive three doses at 6, 10, and 14 weeks of age. Researche…
Phase 2/3 • Sponsor: LG Chem • Aim: Vaccine
Last updated Sep 05, 2026 00:00 UTC
-
Can a new fertility drug match the standard for IVF egg retrieval?
Disease control OngoingThis trial tests whether Fang Le Shu, a recombinant FSH drug, works as well as the standard Gonal-F for ovarian stimulation in women undergoing IVF. About 248 infertile women will receive one of the two drugs to stimulate their ovaries. Researchers will compare the number of eggs…
Phase 4 • Sponsor: LG Chem • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC